MedTrace Logo

Effect of Bosentan on Exercise Capacity at High Altitude

NCT00432978 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2007-04-18

No results posted yet for this study

Summary

This study is to determine whether bosentan will alter exercise capacity after rapid ascent to high altitude.

We hypothesize that bosentan administration will improve arterial oxygenation and exercise capacity.

Conditions

  • Altitude
  • Pulmonary Hypertension

Interventions

DRUG

Bosentan administration

Sponsors & Collaborators

  • Actelion

    collaborator INDUSTRY

  • VA Loma Linda Health Care System

    lead FED

Principal Investigators

  • James D Anholm, MD · VA Loma Linda Healthcare System

  • Katja Ruh, MD · Loma Linda University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00432978 on ClinicalTrials.gov